BACKGROUND: Heart failure is characterized by impaired function and disturbed Ca2+ homeostasis. Transgenic increases in inhibitor-1 activity have been shown to improve Ca2 cycling and preserve cardiac performance in the failing heart. The aim of this study was to evaluate the effect of activating the inhibitor (I-1c) of protein phosphatase 1 (I-1) through gene transfer on cardiac function in a porcine model of heart failure induced by myocardial infarction. METHODS AND RESULTS: Myocardial infarction was created by a percutaneous, permanent left anterior descending artery occlusion in Yorkshire Landrace swine (n=16). One month after myocardial infarction, pigs underwent intracoronary delivery of either recombinant adeno-associated virus type 9 carrying I-1c (n=8) or saline (n=6) as control. One month after myocardial infarction was created, animals exhibited severe heart failure demonstrated by decreased ejection fraction (46.4±7.0% versus sham 69.7±8.5%) and impaired (dP/dt)max and (dP/dt)min. Intracoronary injection of AAV9.I-1c prevented further deterioration of cardiac function and led to a decrease in scar size. CONCLUSIONS: In this preclinical model of heart failure, overexpression of I-1c by intracoronary in vivo gene transfer preserved cardiac function and reduced the scar size.
BACKGROUND:Heart failure is characterized by impaired function and disturbed Ca2+ homeostasis. Transgenic increases in inhibitor-1 activity have been shown to improve Ca2 cycling and preserve cardiac performance in the failing heart. The aim of this study was to evaluate the effect of activating the inhibitor (I-1c) of protein phosphatase 1 (I-1) through gene transfer on cardiac function in a porcine model of heart failure induced by myocardial infarction. METHODS AND RESULTS:Myocardial infarction was created by a percutaneous, permanent left anterior descending artery occlusion in Yorkshire Landrace swine (n=16). One month after myocardial infarction, pigs underwent intracoronary delivery of either recombinant adeno-associated virus type 9 carrying I-1c (n=8) or saline (n=6) as control. One month after myocardial infarction was created, animals exhibited severe heart failure demonstrated by decreased ejection fraction (46.4±7.0% versus sham 69.7±8.5%) and impaired (dP/dt)max and (dP/dt)min. Intracoronary injection of AAV9.I-1c prevented further deterioration of cardiac function and led to a decrease in scar size. CONCLUSIONS: In this preclinical model of heart failure, overexpression of I-1c by intracoronary in vivo gene transfer preserved cardiac function and reduced the scar size.
Authors: Andrew N Carr; Albrecht G Schmidt; Yoichi Suzuki; Federica del Monte; Yoji Sato; Carita Lanner; Kristine Breeden; Shao-Ling Jing; Patrick B Allen; Paul Greengard; Atsuko Yatani; Brian D Hoit; Ingrid L Grupp; Roger J Hajjar; Anna A DePaoli-Roach; Evangelia G Kranias Journal: Mol Cell Biol Date: 2002-06 Impact factor: 4.272
Authors: Anand Pathak; Federica del Monte; Wen Zhao; Jo-El Schultz; John N Lorenz; Ilona Bodi; Doug Weiser; Harvey Hahn; Andrew N Carr; Faisal Syed; Nirmala Mavila; Leena Jha; Jiang Qian; Yehia Marreez; Guoli Chen; Dennis W McGraw; E Kevin Heist; J Luis Guerrero; Anna A DePaoli-Roach; Roger J Hajjar; Evangelia G Kranias Journal: Circ Res Date: 2005-03-03 Impact factor: 17.367
Authors: J Neumann; T Eschenhagen; L R Jones; B Linck; W Schmitz; H Scholz; N Zimmermann Journal: J Mol Cell Cardiol Date: 1997-01 Impact factor: 5.000
Authors: Ali El-Armouche; Katrin Wittköpper; Franziska Degenhardt; Florian Weinberger; Michael Didié; Ivan Melnychenko; Michael Grimm; Micha Peeck; Wolfram H Zimmermann; Bernhard Unsöld; Gerd Hasenfuss; Dobromir Dobrev; Thomas Eschenhagen Journal: Cardiovasc Res Date: 2008-08-08 Impact factor: 10.787
Authors: Brian E Jaski; Mariell L Jessup; Donna M Mancini; Thomas P Cappola; Daniel F Pauly; Barry Greenberg; Kenneth Borow; Howard Dittrich; Krisztina M Zsebo; Roger J Hajjar Journal: J Card Fail Date: 2009-04 Impact factor: 5.712
Authors: Roger J Hajjar; Krisztina Zsebo; Lawrence Deckelbaum; Craig Thompson; Jeff Rudy; Alex Yaroshinsky; Hung Ly; Yoshiaki Kawase; Kim Wagner; Kenneth Borow; Brian Jaski; Barry London; Barry Greenberg; Daniel F Pauly; Richard Patten; Randall Starling; Donna Mancini; Mariell Jessup Journal: J Card Fail Date: 2008-05-27 Impact factor: 5.712
Authors: Filippo Cademartiri; Ludovico La Grutta; Roberto Malagò; Filippo Alberghina; Willem B Meijboom; Francesca Pugliese; Erica Maffei; Anselmo Alessandro Palumbo; Annachiara Aldrovandi; Michele Fusaro; Valerio Brambilla; Paolo Coruzzi; Massimo Midiri; Nico R A Mollet; Gabriel P Krestin Journal: Eur Radiol Date: 2008-02-02 Impact factor: 5.315
Authors: Kiyotake Ishikawa; Kenneth M Fish; Lisa Tilemann; Kleopatra Rapti; Jaume Aguero; Carlos G Santos-Gallego; Ahyoung Lee; Ioannis Karakikes; Chaoqin Xie; Fadi G Akar; Yuichi J Shimada; Judith K Gwathmey; Aravind Asokan; Scott McPhee; Jade Samulski; Richard Jude Samulski; Daniel C Sigg; Thomas Weber; Evangelia G Kranias; Roger J Hajjar Journal: Mol Ther Date: 2014-07-15 Impact factor: 11.454
Authors: Michael G Katz; Anthony S Fargnoli; Thomas Weber; Roger J Hajjar; Charles R Bridges Journal: Hum Gene Ther Clin Dev Date: 2017-07-19 Impact factor: 5.032